These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 19289394)
21. [Milroy's disease and primary lymphoedema. Exploration methods, therapeutic aspects (author's transl)]. Stalder JF; Berger M Ann Dermatol Venereol; 1980 Jul; 107(7):665-7. PubMed ID: 7436261 [TBL] [Abstract][Full Text] [Related]
22. A novel stop mutation in the vascular endothelial growth factor-C gene (VEGFC) results in Milroy-like disease. Balboa-Beltran E; Fernández-Seara MJ; Pérez-Muñuzuri A; Lago R; García-Magán C; Couce ML; Sobrino B; Amigo J; Carracedo A; Barros F J Med Genet; 2014 Jul; 51(7):475-8. PubMed ID: 24744435 [TBL] [Abstract][Full Text] [Related]
23. Role of the VEGFR3/VEGFD receptor axis in TGFbeta1 activation of primary prostate cell lines. Goodyear SM; Kheyfets SB; Garcia FU; Stearns ME Prostate; 2009 Jun; 69(9):982-90. PubMed ID: 19301310 [TBL] [Abstract][Full Text] [Related]
24. A novel FLT4 mutation identified in a patient with Milroy disease. DiGiovanni RM; Erickson RP; Ohlson EC; Bernas M; Witte MH Lymphology; 2014 Mar; 47(1):44-7. PubMed ID: 25109169 [TBL] [Abstract][Full Text] [Related]
25. Identification of eight novel VEGFR-3 mutations in families with primary congenital lymphoedema. Evans AL; Bell R; Brice G; Comeglio P; Lipede C; Jeffery S; Mortimer P; Sarfarazi M; Child AH J Med Genet; 2003 Sep; 40(9):697-703. PubMed ID: 12960217 [No Abstract] [Full Text] [Related]
26. Hydrops fetalis: an unusual prenatal presentation of hereditary congenital lymphedema. Daniel-Spiegel E; Ghalamkarpour A; Spiegel R; Weiner E; Vikkula M; Shalev E; Shalev SA Prenat Diagn; 2005 Nov; 25(11):1015-8. PubMed ID: 16231305 [TBL] [Abstract][Full Text] [Related]
27. Alport syndrome. Molecular genetic aspects. Hertz JM Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970 [TBL] [Abstract][Full Text] [Related]
28. Wide clinical spectrum in a family with hereditary lymphedema type I due to a novel missense mutation in VEGFR3. Spiegel R; Ghalamkarpour A; Daniel-Spiegel E; Vikkula M; A Shalev S J Hum Genet; 2006; 51(10):846-850. PubMed ID: 16924388 [TBL] [Abstract][Full Text] [Related]
30. Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores. Monnier N; Marty I; Faure J; Castiglioni C; Desnuelle C; Sacconi S; Estournet B; Ferreiro A; Romero N; Laquerriere A; Lazaro L; Martin JJ; Morava E; Rossi A; Van der Kooi A; de Visser M; Verschuuren C; Lunardi J Hum Mutat; 2008 May; 29(5):670-8. PubMed ID: 18253926 [TBL] [Abstract][Full Text] [Related]
31. A recurrent ITGA9 missense mutation in human fetuses with severe chylothorax: possible correlation with poor response to fetal therapy. Ma GC; Liu CS; Chang SP; Yeh KT; Ke YY; Chen TH; Wang BB; Kuo SJ; Shih JC; Chen M Prenat Diagn; 2008 Nov; 28(11):1057-63. PubMed ID: 18973153 [TBL] [Abstract][Full Text] [Related]
32. Of mice and men; the translational physiology of a genetic form of lymphoedema. Mortimer PS; Levick JR J Physiol; 2006 Jul; 574(Pt 2):331. PubMed ID: 16728443 [No Abstract] [Full Text] [Related]
33. FLT4 causes developmental disorders of the cardiovascular and lymphovascular systems via pleiotropic molecular mechanisms. Monaghan RM; Naylor RW; Flatman D; Kasher PR; Williams SG; Keavney BD Cardiovasc Res; 2024 Sep; 120(10):1164-1176. PubMed ID: 38713105 [TBL] [Abstract][Full Text] [Related]
34. Functional analysis of FLT4 mutations associated with Nonne-Milroy lymphedema. Verstraeten VL; Holnthoner W; van Steensel MA; Veraart JC; Bladergroen RS; Heckman CA; Keskitalo S; Frank J; Alitalo K; van Geel M; Steijlen PM J Invest Dermatol; 2009 Feb; 129(2):509-12. PubMed ID: 18719607 [No Abstract] [Full Text] [Related]